How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset. But only if the data is in a useful and accessible form.
Unfortunately, too often customer data is buried in difficult-to-access legacy systems or siloed with clinical, medical, or commercial stakeholders. In this white paper from Veeva Systems, Navigating Customer Data Fragmentation in Biopharma, discover the costs of fragmented data, the challenges of harmonising that data and, finally, strategies for achieving success.
Customer data fragmentation can cost $12.9 million over the course of the year, according to data from Gartner. Fragmented or poorly categorised data can lead to inefficient processes, higher resource utilisation, and inaccurate reporting.
On the other hand, a harmonised, unified data infrastructure can lead to new efficiencies among internal teams and allows the application of AI to glean insights for omnichannel implementations. Data harmonisation is the foundation on which a good omnichannel strategy must be built.
With the Veeva white paper Navigating Customer Data Fragmentation in Biopharma, readers can learn to be on the right side of this tricky reality in biopharma today.
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world’s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
